ArticleFrontiers in oncology2024

VISTA/CTLA4/PD1 coexpression on tumor cells confers a favorable immune microenvironment and better prognosis in high-grade serous ovarian carcinoma.

Aida Jlassi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.